AROPEM

This brand name is authorized in Nigeria.

Active ingredients

The drug AROPEM contains one active pharmaceutical ingredient (API):

1	Meropenem UNII FV9J3JU8B1 - MEROPENEM
	Meropenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs).
	Read more about Meropenem

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1483	Powder for solution for injection/infusion	Aropem 1 g Injection INJ_PWD_F_SOL 1 g	Powder for Solution for Injection or Infusion in a vial	21/12/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DH02	Meropenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1483